BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30871861)

  • 21. From Oxadiazole to Triazole Analogues: Optimization toward a Dual Orexin Receptor Antagonist with Improved in vivo Efficacy in Dogs.
    Brotschi C; Bolli MH; Gatfield J; Heidmann B; Jenck F; Roch C; Sifferlen T; Treiber A; Williams JT; Boss C
    ChemMedChem; 2020 Mar; 15(5):430-448. PubMed ID: 31945272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation.
    Hong C; Byrne NJ; Zamlynny B; Tummala S; Xiao L; Shipman JM; Partridge AT; Minnick C; Breslin MJ; Rudd MT; Stachel SJ; Rada VL; Kern JC; Armacost KA; Hollingsworth SA; O'Brien JA; Hall DL; McDonald TP; Strickland C; Brooun A; Soisson SM; Hollenstein K
    Nat Commun; 2021 Feb; 12(1):815. PubMed ID: 33547286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists.
    Skudlarek JW; DiMarco CN; Babaoglu K; Roecker AJ; Bruno JG; Pausch MA; O'Brien JA; Cabalu TD; Stevens J; Brunner J; Tannenbaum PL; Wuelfing WP; Garson SL; Fox SV; Savitz AT; Harrell CM; Gotter AL; Winrow CJ; Renger JJ; Kuduk SD; Coleman PJ
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1364-1370. PubMed ID: 28216403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of ORN0829, a potent dual orexin 1/2 receptor antagonist for the treatment of insomnia.
    Futamura A; Suzuki R; Tamura Y; Kawamoto H; Ohmichi M; Hino N; Tokumaru Y; Kirinuki S; Hiyoshi T; Aoki T; Kambe D; Nozawa D
    Bioorg Med Chem; 2020 Jul; 28(13):115489. PubMed ID: 32482533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.
    Rappas M; Ali AAE; Bennett KA; Brown JD; Bucknell SJ; Congreve M; Cooke RM; Cseke G; de Graaf C; Doré AS; Errey JC; Jazayeri A; Marshall FH; Mason JS; Mould R; Patel JC; Tehan BG; Weir M; Christopher JA
    J Med Chem; 2020 Feb; 63(4):1528-1543. PubMed ID: 31860301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of novel orexin 2 receptor agonists based on naphthalene skeleton.
    Hino T; Saitoh T; Nagumo Y; Yamamoto N; Kutsumura N; Irukayama-Tomobe Y; Ishikawa Y; Tanimura R; Yanagisawa M; Nagase H
    Bioorg Med Chem Lett; 2022 Mar; 59():128530. PubMed ID: 35007725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of orexin receptors in the ventral tegmental area on acquisition and expression of morphine-induced conditioned place preference in the rats.
    Farahimanesh S; Zarrabian S; Haghparast A
    Neuropeptides; 2017 Dec; 66():45-51. PubMed ID: 28890208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A.
    Messal N; Fernandez N; Dayot S; Gratio V; Nicole P; Prochasson C; Chantret I; LeGuilloux G; Jarry A; Couvelard A; Tréton X; Voisin T; Ogier-Denis E; Couvineau A
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3618-3628. PubMed ID: 30251681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands.
    Turku A; Borrel A; Leino TO; Karhu L; Kukkonen JP; Xhaard H
    J Med Chem; 2016 Sep; 59(18):8263-75. PubMed ID: 27546834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach.
    Heidmann B; Gatfield J; Roch C; Treiber A; Tortoioli S; Brotschi C; Williams JT; Bolli MH; Abele S; Sifferlen T; Jenck F; Boss C
    ChemMedChem; 2016 Oct; 11(19):2132-2146. PubMed ID: 27390287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation.
    Vitale RM; Iannotti FA; Schiano Moriello A; Tunisi L; Piscitelli F; Savopoulos R; Cristino L; De Petrocellis L; Amodeo P; Gray R; Di Marzo V
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of Orexin Receptor Binding and Activation-A Molecular Dynamics Study.
    Karhu L; Magarkar A; Bunker A; Xhaard H
    J Phys Chem B; 2019 Mar; 123(12):2609-2622. PubMed ID: 30786708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both Ox1R and Ox2R orexin receptors contribute to the cardiorespiratory response evoked from the perifornical hypothalamus.
    Beig MI; Horiuchi J; Dampney RA; Carrive P
    Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1059-67. PubMed ID: 26174505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists.
    Zhang D; Perrey DA; Decker AM; Langston TL; Mavanji V; Harris DL; Kotz CM; Zhang Y
    J Med Chem; 2021 Jun; 64(12):8806-8825. PubMed ID: 34101446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements.
    Roecker AJ; Mercer SP; Bergman JM; Gilbert KF; Kuduk SD; Harrell CM; Garson SL; Fox SV; Gotter AL; Tannenbaum PL; Prueksaritanont T; Cabalu TD; Cui D; Lemaire W; Winrow CJ; Renger JJ; Coleman PJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4992-4999. PubMed ID: 25613676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors.
    Huang B; Gunta R; Wang H; Li M; Cao D; Mendez RE; Gillespie JC; Chen C; Huang LM; Liu-Chen LY; Selley DE; Zhang Y
    Bioorg Chem; 2021 Apr; 109():104702. PubMed ID: 33631465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Based Discovery of Novel Ligands for the Orexin 2 Receptor.
    Gunera J; Baker JG; van Hilten N; Rosenbaum DM; Kolb P
    J Med Chem; 2020 Oct; 63(19):11045-11053. PubMed ID: 32977721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of trigeminal nucleus caudalis orexin 1 receptors in orofacial pain transmission and in orofacial pain-induced learning and memory impairment in rats.
    Kooshki R; Abbasnejad M; Esmaeili-Mahani S; Raoof M
    Physiol Behav; 2016 Apr; 157():20-7. PubMed ID: 26821188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of orexin-1 and orexin-2 receptors within the dentate gyrus of the hippocampus in the acquisition, expression and extinction of lateral hypothalamic-induced conditioned place preference in the rats.
    Parsania S; Moradi M; Fatahi Z; Haghparast A
    Brain Res; 2016 May; 1639():149-60. PubMed ID: 26987804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the orexin (hypocretin) system in contextual fear conditioning in rats.
    Wang H; Li S; Kirouac GJ
    Behav Brain Res; 2017 Jan; 316():47-53. PubMed ID: 27575948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.